Recent research (1) that shows Graphene could be utilized to interact with neurons open up a new avenue for research and practice to cure cognitive disabilities and possibly treat CNS diseases. More importantly, this is a profitable direction for biosciences to accelerate innovation. From the moment humans figured out they could impact the system by the ingestion of chemicals, they have been focused singularly on that. The system, however, is clearly electromagnetochemical, providing plenty of opportunities for more elegant interventions without multifactorial and unpredictable long term effects. Chemistry, has plateaued and life sciences companies with a vision of the future, have to move in a direction they are uncomfortable with.
Such an innovative departure in life sciences will take new leadership and a collaboration with emerging ideas and technologies. The impact will be far reaching - possibly replacing chemicals as the only non-invasive intervention. Medical education has to consider robotics, precision electronics and even high energy physics. Computer science and information science have to become integral to diagnosis and treatment. The meaning of intervention has to change - with impacts on the brain and the body simultaneously for optimum effect. In a regime of subdued bugs, unable to threaten the mighty human, it is going to be a battle against the body and the mind. Here, chemicals fail.
Innovation in life sciences will not come from incremental improvements to existing therapies, it will come from embracing hitherto unknown intervention modalities.